IN2015KN00201A - - Google Patents
Info
- Publication number
- IN2015KN00201A IN2015KN00201A IN201KON2015A IN2015KN00201A IN 2015KN00201 A IN2015KN00201 A IN 2015KN00201A IN 201KON2015 A IN201KON2015 A IN 201KON2015A IN 2015KN00201 A IN2015KN00201 A IN 2015KN00201A
- Authority
- IN
- India
- Prior art keywords
- calcium
- zirconium silicate
- silicate compositions
- microporous zirconium
- hyperkalemia
- Prior art date
Links
- 239000011575 calcium Substances 0.000 abstract 3
- 229910052791 calcium Inorganic materials 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 abstract 2
- 208000037147 Hypercalcaemia Diseases 0.000 abstract 1
- 208000002682 Hyperkalemia Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 229910001414 potassium ion Inorganic materials 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0006—Controlling or regulating processes
- B01J19/0013—Controlling the temperature of the process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/006—Baffles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/0066—Stirrers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/18—Stationary reactors having moving elements inside
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/02—Processes using inorganic exchangers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/14—Base exchange silicates, e.g. zeolites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/025—Silicon compounds without C-silicon linkages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00054—Controlling or regulating the heat exchange system
- B01J2219/00056—Controlling or regulating the heat exchange system involving measured parameters
- B01J2219/00058—Temperature measurement
- B01J2219/00063—Temperature measurement of the reactants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00094—Jackets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00761—Details of the reactor
- B01J2219/00763—Baffles
- B01J2219/00765—Baffles attached to the reactor wall
- B01J2219/00768—Baffles attached to the reactor wall vertical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Geology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670415P | 2012-07-11 | 2012-07-11 | |
| US201361800291P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/050071 WO2014011876A2 (fr) | 2012-07-11 | 2013-07-11 | Silicate de zirconium microporeux destiné au traitement de l'hyperkaliémie chez des patients hypercalcémiques et compositions améliorées contenant du calcium destinées au traitement de l'hyperkaliémie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015KN00201A true IN2015KN00201A (fr) | 2015-06-12 |
Family
ID=49916686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN201KON2015 IN2015KN00201A (fr) | 2012-07-11 | 2013-07-11 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9707255B2 (fr) |
| EP (1) | EP2872148A4 (fr) |
| JP (1) | JP2015529640A (fr) |
| KR (1) | KR20150036555A (fr) |
| CN (1) | CN104968336A (fr) |
| AU (1) | AU2013290141A1 (fr) |
| BR (1) | BR112015000636A2 (fr) |
| CA (1) | CA2878832A1 (fr) |
| CL (1) | CL2015000078A1 (fr) |
| CO (1) | CO7200258A2 (fr) |
| HK (2) | HK1209029A1 (fr) |
| IL (1) | IL236655A0 (fr) |
| IN (1) | IN2015KN00201A (fr) |
| MX (1) | MX2015000381A (fr) |
| PH (1) | PH12015500071A1 (fr) |
| WO (1) | WO2014011876A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2673237T2 (sl) * | 2011-02-11 | 2025-12-31 | Zs Pharma, Inc | Uporaba cirkonijevega silikata v zdravljenju hiperkalemije |
| CN104968336A (zh) | 2012-07-11 | 2015-10-07 | Zs制药公司 | 用于治疗高钙血症患者高钾血症的微孔硅酸锆以及用于治疗高钾血症的改进的含钙组合物 |
| BR112015025438B1 (pt) * | 2013-04-05 | 2022-06-07 | Zs Pharma, Inc | Uso de um silicato de zircônio |
| US20160038538A1 (en) * | 2013-11-08 | 2016-02-11 | ZS Pharma, Inc. | Microporous zirconium silicate for the treatment of hyperkalemia |
| CA2929978C (fr) * | 2013-11-08 | 2021-11-30 | ZS Pharma, Inc. | Silicate de zirconium microporeux pour le traitement de l'hyperkaliemie |
| US9592253B1 (en) * | 2015-10-14 | 2017-03-14 | ZS Pharma, Inc. | Extended use zirconium silicate compositions and methods of use thereof |
| US11964266B2 (en) | 2019-07-09 | 2024-04-23 | Uop Llc | Process for removing cobalt, lead, cadmium and chromium ions from bodily fluids using metallate ion exchange compositions |
| US11577014B2 (en) | 2019-07-09 | 2023-02-14 | Uop Llc | Process for removing strontium ions from bodily fluids using metallate ion exchange compositions |
| US11484875B2 (en) | 2019-07-09 | 2022-11-01 | Uop Llc | Process for removing mercury ions from bodily fluids using titanium metallate ion exchange compositions |
| TWI732489B (zh) * | 2020-03-17 | 2021-07-01 | 國防醫學院 | 應用心電圖快速偵測鉀離子異常之方法及其系統 |
| US12036528B2 (en) | 2020-09-30 | 2024-07-16 | Uop Llc | Process for removing lead ions from boldily fluids using metallate ion exchange compositions |
| CN119643609A (zh) * | 2025-02-17 | 2025-03-18 | 北京华睿鼎信科技有限公司 | 一种晶相杂质的分析方法 |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3329480A (en) | 1963-10-18 | 1967-07-04 | Union Oil Co | Crystalline zircono-silicate zeolites |
| US3947279A (en) | 1971-12-23 | 1976-03-30 | Owens-Illinois, Inc. | Thermally crystallizable glasses possessing precision controlled crystallization and flow properties and process of producing same |
| US3959445A (en) * | 1973-04-30 | 1976-05-25 | E. I. Du Pont De Nemours And Company | Highly absorbent, low bulk density sodium silicate |
| US4581141A (en) | 1978-02-27 | 1986-04-08 | Purdue Research Foundation | Dialysis material and method for removing uremic substances |
| FR2444005A1 (fr) * | 1978-12-15 | 1980-07-11 | Ugine Kuhlmann | Procede industriel de fabrication en semi-continu de zeolithe a |
| LU84743A1 (fr) * | 1983-04-11 | 1984-11-28 | Sipac | Procede de fabrication de zeolite a et produits obtenus |
| US4943545A (en) * | 1987-06-08 | 1990-07-24 | Mobil Oil Corporation | Activation of zeolites |
| US5032556A (en) | 1989-02-21 | 1991-07-16 | Tosoh Corporation | Preparation method for zircon powder |
| US5015453A (en) | 1989-04-28 | 1991-05-14 | W. R. Grace & Co.-Conn. | Crystalline group IVA metal-containing molecular sieve compositions |
| JP3265344B2 (ja) | 1990-03-16 | 2002-03-11 | 東ソー株式会社 | ジルコン粉末の合成法 |
| US5338527A (en) | 1992-08-20 | 1994-08-16 | Uop | Zirconium silicate composition, method of preparation and uses thereof |
| ES2092334T5 (es) | 1992-10-28 | 2003-01-16 | Ineos Silicas Ltd | Silices. |
| US5518707A (en) | 1994-10-24 | 1996-05-21 | Uop | Metallo germanates |
| GB9601398D0 (en) | 1996-01-24 | 1996-03-27 | Piper Edwina M | Composition |
| IT1283284B1 (it) | 1996-03-21 | 1998-04-16 | Eniricerche Spa | Zeolite ers-10 e procedimento per la sua preparazione |
| FR2750893B1 (fr) | 1996-07-12 | 1998-10-30 | Elf Aquitaine | Procede de synthese de zeolithe avec agitation homogene du milieu, dispositif et application |
| CA2214495C (fr) | 1996-09-25 | 2002-02-05 | Daniel L. Woodard | Composition de silicate de zirconium hydrate servant a purifier des acides nucleiques |
| US5888472A (en) | 1997-04-08 | 1999-03-30 | Uop Llc | Zirconium silicate molecular sieves and process using the same |
| US5891417A (en) | 1997-04-08 | 1999-04-06 | Uop Llc | Zirconium silicate and zirconium germanate molecular sieves and process using the same |
| CA2268888A1 (fr) | 1997-05-12 | 1998-11-19 | Itsuki Uehara | Separateur pour accumulateur et accumulateur electrique alcalin l'utilisant |
| JPH11292769A (ja) * | 1998-04-10 | 1999-10-26 | Toyo Seiyaku Kasei Kk | 高カリウム血症改善剤組成物 |
| US6007790A (en) | 1998-08-13 | 1999-12-28 | Uop Llc | Family of microporous indium silicate compositions |
| US5989518A (en) * | 1998-12-29 | 1999-11-23 | Uop Llc | Process for synthesizing and controlling the particle size and particle size distribution of a molecular sieve |
| EP1038580B1 (fr) | 1999-03-26 | 2005-05-25 | Uop Llc | Procédé d'adsorption d'ions ammonium utilisant des tamis moléculaires à base de silicate de zirconium et germanate de zirconium |
| US6332985B1 (en) * | 1999-03-29 | 2001-12-25 | Uop Llc | Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions |
| US6099737A (en) | 1999-03-29 | 2000-08-08 | Uop Llc | Process for removing toxins from blood using zirconium metallate or titanium metallate compositions |
| US7041274B2 (en) | 1999-10-22 | 2006-05-09 | Intevep, S.A. | Aluminosilicate compositions, preparation and use |
| US6379641B1 (en) | 2000-05-01 | 2002-04-30 | Uop Llc | Microporous rare earth silicates and method of producing same |
| US6596254B1 (en) | 2000-06-12 | 2003-07-22 | Sandia Corporation | Niobate-based octahedral molecular sieves |
| AU2002242103A1 (en) | 2001-02-06 | 2002-08-19 | Ash Medical Systems, Inc. | Monovalent-selective cation exchangers as oral sorbent therapy |
| US6579460B1 (en) | 2001-03-13 | 2003-06-17 | Uop Llc | Process and composition for removing toxins from bodily fluids |
| US6814871B1 (en) | 2001-07-13 | 2004-11-09 | Uop Llc | Process for removing pollutants from aqueous streams |
| JP2004149525A (ja) * | 2002-10-09 | 2004-05-27 | Sekisui Chem Co Ltd | カリウムイオン吸着剤及びその製造方法、並びに高カリウム血症治療剤 |
| US6689335B1 (en) | 2002-12-19 | 2004-02-10 | Eastman Kodak Company | Silver ion sequester and release agent |
| US6984403B2 (en) | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| KR100804360B1 (ko) | 2003-12-15 | 2008-02-15 | 아사히 가세이 케미칼즈 가부시키가이샤 | 다공성 성형체 및 그의 제조 방법 |
| US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
| BRPI0509365B8 (pt) * | 2004-03-30 | 2021-05-25 | Ilypsa Inc | composição farmacêutica, kit farmacêutico, e, uso da referida composição |
| US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
| US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
| US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
| EP2599547B1 (fr) | 2004-12-28 | 2019-03-27 | Renal Solutions, Inc. | Procédé de synthèse de particules de phosphate de zirconium |
| KR101005388B1 (ko) | 2005-06-14 | 2010-12-30 | 아사히 가세이 케미칼즈 가부시키가이샤 | 수처리 장치 및 수처리 방법 |
| WO2007041569A1 (fr) | 2005-09-30 | 2007-04-12 | Ilypsa, Inc. | Methodes et compositions permettant d'eliminer selectivement des ions potassium du tube digestif d'un mammifere |
| BRPI0616603A2 (pt) * | 2005-09-30 | 2012-12-25 | Ilypsa Inc | mÉtodo para preparar um compàsito de nécleo-envoltàrio, e para a manufatura de um medicamento, composiÇço farmacÊutica, e, uso da mesma |
| US8367112B2 (en) | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
| WO2007127390A2 (fr) | 2006-04-28 | 2007-11-08 | Biolife, L.L.C. | Matières et procédés pour le traitement de plaies |
| US20080292695A1 (en) | 2006-12-01 | 2008-11-27 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
| KR101002571B1 (ko) | 2007-01-03 | 2010-12-17 | 주식회사 인실리코텍 | 다공성 금속-유기 골격 구조를 갖는 배위중합체 결정 및이의 제조방법 |
| ES2304890B1 (es) | 2007-04-03 | 2009-10-30 | Universidad De Zaragoza | Procedimiento de obtencion de esferas de titanosilicato. |
| EP3138822B1 (fr) | 2008-02-26 | 2023-07-26 | Corning Incorporated | Agents de finition pour verres à base de silicate |
| WO2010022381A1 (fr) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Traitement d'une hyperkaliémie par des polymères d'échange de cation réticulés ayant des propriétés physiques améliorées |
| WO2010144865A2 (fr) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Procédés de traitement de troubles gastro-intestinaux |
| US8865121B2 (en) | 2009-06-18 | 2014-10-21 | Basf Se | Organotemplate-free synthetic process for the production of a zeolitic material |
| US20120070468A1 (en) | 2010-09-16 | 2012-03-22 | Uop Llc | Removal of toxins from gastrointestinal fluids |
| SI2673237T2 (sl) | 2011-02-11 | 2025-12-31 | Zs Pharma, Inc | Uporaba cirkonijevega silikata v zdravljenju hiperkalemije |
| EP2694437B1 (fr) | 2011-04-08 | 2020-10-21 | Basf Se | Procédé de production d'un catalyseur d'acylation |
| US10092688B2 (en) | 2011-05-13 | 2018-10-09 | Laura Jean Robinson | Medicament kit and method of use |
| US9527751B2 (en) | 2011-11-11 | 2016-12-27 | Basf Se | Organotemplate-free synthetic process for the production of a zeolitic material of the CHA-type structure |
| US20130202524A1 (en) | 2012-02-06 | 2013-08-08 | Basf Se | Iron- And Copper-Containing Zeolite Beta From Organotemplate-Free Synthesis And Use Thereof In The Selective Catalytic Reduction Of NOx |
| US9475041B2 (en) | 2012-04-24 | 2016-10-25 | Basf Se | Zeolitic materials and methods for their preparation using alkenyltrialkylammonium compounds |
| CN104968336A (zh) | 2012-07-11 | 2015-10-07 | Zs制药公司 | 用于治疗高钙血症患者高钾血症的微孔硅酸锆以及用于治疗高钾血症的改进的含钙组合物 |
| CN104797263B (zh) | 2012-10-22 | 2018-02-09 | Zs制药公司 | 用于治疗高钾血症的微孔硅酸锆 |
-
2013
- 2013-07-11 CN CN201380047054.7A patent/CN104968336A/zh active Pending
- 2013-07-11 CA CA2878832A patent/CA2878832A1/fr not_active Abandoned
- 2013-07-11 HK HK15109434.8A patent/HK1209029A1/xx unknown
- 2013-07-11 IN IN201KON2015 patent/IN2015KN00201A/en unknown
- 2013-07-11 MX MX2015000381A patent/MX2015000381A/es unknown
- 2013-07-11 AU AU2013290141A patent/AU2013290141A1/en not_active Abandoned
- 2013-07-11 WO PCT/US2013/050071 patent/WO2014011876A2/fr not_active Ceased
- 2013-07-11 EP EP13817161.6A patent/EP2872148A4/fr not_active Withdrawn
- 2013-07-11 KR KR1020157003699A patent/KR20150036555A/ko not_active Withdrawn
- 2013-07-11 JP JP2015521806A patent/JP2015529640A/ja active Pending
- 2013-07-11 HK HK16103833.7A patent/HK1215861A1/zh unknown
- 2013-07-11 US US13/939,656 patent/US9707255B2/en active Active
- 2013-07-11 BR BR112015000636A patent/BR112015000636A2/pt active Search and Examination
-
2015
- 2015-01-11 IL IL236655A patent/IL236655A0/en unknown
- 2015-01-12 CL CL2015000078A patent/CL2015000078A1/es unknown
- 2015-01-12 PH PH12015500071A patent/PH12015500071A1/en unknown
- 2015-02-09 CO CO15025901A patent/CO7200258A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014011876A2 (fr) | 2014-01-16 |
| HK1215861A1 (zh) | 2016-09-23 |
| CN104968336A (zh) | 2015-10-07 |
| HK1209029A1 (en) | 2016-03-24 |
| BR112015000636A2 (pt) | 2017-08-08 |
| JP2015529640A (ja) | 2015-10-08 |
| PH12015500071A1 (en) | 2015-03-16 |
| US20140105971A1 (en) | 2014-04-17 |
| US9707255B2 (en) | 2017-07-18 |
| MX2015000381A (es) | 2015-11-23 |
| KR20150036555A (ko) | 2015-04-07 |
| EP2872148A4 (fr) | 2016-06-15 |
| AU2013290141A1 (en) | 2015-02-05 |
| EP2872148A2 (fr) | 2015-05-20 |
| CL2015000078A1 (es) | 2015-06-05 |
| CO7200258A2 (es) | 2015-02-27 |
| WO2014011876A3 (fr) | 2015-07-16 |
| IL236655A0 (en) | 2015-02-26 |
| CA2878832A1 (fr) | 2014-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015KN00201A (fr) | ||
| PH12015500849A1 (en) | Microporous zirconium silicate for treating hyperkalemia | |
| PH12013501762B1 (en) | Microporous zirconium silicate for the treatment of hyperkalemia | |
| EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201390967A1 (ru) | Специфические для грамположительных бактерий связывающие соединения | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| EA201491505A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| PH12015500274A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| HK1223093A1 (zh) | 杀真菌组合物 | |
| EA033374B9 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| HK1209159A1 (en) | Methods of decellularizing bone | |
| MX366368B (es) | Metodos para el cuidado oral prebiotico usando un sacarido. | |
| PH12016500864A1 (en) | Microporous zirconium silicate for the treatment of hyperkalemia | |
| WO2012065110A3 (fr) | Analogues de cystéine s-protégés et composés associés | |
| SG10201405392RA (en) | Method of treatment of neurodegenerative or neuro-muscular degenerative diseases andtherapeutic agent to treat the same | |
| PH12017501872A1 (en) | Methods of treating diseases | |
| SG194235A1 (en) | Methods of predicting the development of complement-mediated disease | |
| MX347541B (es) | Analogos de acido sialico. | |
| EP2855438A4 (fr) | Nouveaux composés et nouvelles compositions pour le traitement de troubles ou de maladies du contrôle de la respiration | |
| WO2010115741A3 (fr) | Nouvelles approches thérapeutiques destinées au traitement de pathologies inflammatoires | |
| EA201400828A1 (ru) | Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата | |
| LV14848A (lv) | Farmaceitiska kompozīcija trimetilamīna N-oksīda līmeņa pazemināšanai | |
| GB201120259D0 (en) | Allogeneic immune response control |